1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Li Junmin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS) Decitabine, Arsenic Trioxide - Myelodysplastic Syndromes, P53 Mutation | Phase 3 | Withdrawn | Li Junmin | 2018-03-20 | 2023-08-16 |
Arsenic (1) · Arsenic Trioxide (1) · Decitabine (1)
China (1)
Lu Min (1) · Zhang Sujiang (1)